UBS analyst Ashwani Verma upgraded Viatris (VTRS) to Buy from Neutral with a price target of $18, up from $11. The firm cites the company’s improving growth for the upgrade. Viatris’ new product cycle pipeline and cost savings could unlock share value, the analyst tells investors in a research note. The firm likes the company’s growing pipeline, margin expansion and capital allocation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTRS:
- Viatris Announces Chief Legal Officer Transition and Successor
- Viatris appoints Matthew Maletta as Chief Legal Officer
- Viatris price target raised to $12 from $9 at Piper Sandler
- Viatris announces Inpefa launch in the United Arab Emirates
- Argus upgrades Viatris to Buy on expected buybacks, debt reduction